fda 503b bulks list bpc-157 category 2 bulk drug substances FDA Peptide Reclassification 2026: What It Means BPC-157, TB-500, KPV, GHK-Cu 80mg

After spending time on the FDA's Category 2 list flagged for "significant safety concerns" BPC-157 is now being removed from that restrictive classification and scheduled for a Pharmacy Compounding Advisory Committee (PCAC) review on July 23, 2026

Answer: BPC-157 and TB-500 are both synthetic (laboratory-made) peptides that have been promoted for many uses based mainly on findings in animal studies: BPC-157 for improving bone and joint health, stomach ulcers, bladder pain, athletic performance enhancement, and anti-aging effects, and TB-500 for wound healing, injury recovery, strength and endurance

This commonly occurred with all of the used BPC 157 therapeutic regimens as well as at both early and advanced stages (Vukojevic et al., 2018)

After the program, they ranked their learning needs again